Typhoid Vaccine

BreastfeedingPediatric
  • TRADE NAMES: Typherix (GSK); Typhim Vi (Sanofi Pasteur); Vivotif (Berna Biotech)
  • INDICATIONS: Immunization against typhoid fever
  • CLASS: Vaccine
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Antibiotics, Antimalarials, Atovaquone/Proguanil, Azathioprine, Belimumab, Cefixime, Ceftaroline Fosamil, Ceftobiprole, Chloroquine, Ciprofloxacin, Corticosteroids, Daptomycin, Fingolimod, Gemifloxacin, Hydroxychloroquine, Immunosuppressants, Interferon Gamma, Leflunomide, Mefloquine, Mercaptopurine, Sulfonamides, Telavancin, Tigecycline, Tinidazole, Tocilizumab, Ustekinumab

PREGNANCY CATEGORY: C

Vivotif is a live oral vaccine.

Our database has 30 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 02/01/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top